JP2006510658A5 - - Google Patents

Download PDF

Info

Publication number
JP2006510658A5
JP2006510658A5 JP2004558631A JP2004558631A JP2006510658A5 JP 2006510658 A5 JP2006510658 A5 JP 2006510658A5 JP 2004558631 A JP2004558631 A JP 2004558631A JP 2004558631 A JP2004558631 A JP 2004558631A JP 2006510658 A5 JP2006510658 A5 JP 2006510658A5
Authority
JP
Japan
Prior art keywords
composition
effective amount
compound
compound according
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004558631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006510658A (ja
Filing date
Publication date
Priority claimed from US10/313,968 external-priority patent/US7122573B2/en
Application filed filed Critical
Publication of JP2006510658A publication Critical patent/JP2006510658A/ja
Publication of JP2006510658A5 publication Critical patent/JP2006510658A5/ja
Pending legal-status Critical Current

Links

JP2004558631A 2002-12-06 2003-12-08 化学療法剤および化学予防剤としての緑茶ポリフェノールのアナログ Pending JP2006510658A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/313,968 US7122573B2 (en) 2002-12-06 2002-12-06 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents
PCT/US2003/039191 WO2004052873A2 (en) 2002-12-06 2003-12-08 Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents

Publications (2)

Publication Number Publication Date
JP2006510658A JP2006510658A (ja) 2006-03-30
JP2006510658A5 true JP2006510658A5 (enExample) 2006-10-26

Family

ID=32468383

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004558631A Pending JP2006510658A (ja) 2002-12-06 2003-12-08 化学療法剤および化学予防剤としての緑茶ポリフェノールのアナログ

Country Status (6)

Country Link
US (2) US7122573B2 (enExample)
EP (1) EP1581512A2 (enExample)
JP (1) JP2006510658A (enExample)
AU (1) AU2003297802A1 (enExample)
CA (1) CA2508020A1 (enExample)
WO (1) WO2004052873A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE346059T1 (de) * 1999-08-16 2006-12-15 Dsm Ip Assets Bv Verfahren zu herstellung von epigallocatechin gallate
AU2012200214B2 (en) * 2004-05-14 2013-10-24 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
GB0415181D0 (en) * 2004-07-06 2004-08-11 School Of Pharmacy The Univers Compounds for use in the treatment of infection
ES2660339T3 (es) * 2004-08-19 2018-03-21 The Hong Kong Polytechnic University Derivados de galato de (-)-epigalocatequina para inhibir el proteasoma
US9446017B2 (en) 2005-08-11 2016-09-20 Augusta University Research Institute, Inc. Compositions and methods for treating herpes simplex virus
US8076484B2 (en) 2005-08-11 2011-12-13 Georgia Health Science University Research Institute, Inc. Modified green tea polyphenol formulations
JP5128826B2 (ja) * 2007-02-07 2013-01-23 独立行政法人農業・食品産業技術総合研究機構 新規なメチル化カテキン及びそれを含む組成
US20080311252A1 (en) * 2007-06-13 2008-12-18 Selzer Jonathan A Chocolate based dietary supplement product or sweet beverage product
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
WO2009107262A1 (ja) * 2008-02-25 2009-09-03 学校法人 久留米大学 ３”メチル化エピガロカテキンガレート含有抗癌剤組成物
WO2010019914A2 (en) * 2008-08-14 2010-02-18 The Uab Research Foundation Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre
JP2011162506A (ja) * 2010-02-12 2011-08-25 Tokyo Institute Of Technology エピガロカテキンガレート誘導体及びそれを含む医薬組成物
PL2597960T3 (pl) * 2010-07-30 2014-08-29 Unilever Nv Sposób fabrykowania produktów liściastej herbaty
US8986770B2 (en) 2010-07-30 2015-03-24 Conopco, Inc. Process for fabricating leaf tea products
US9556140B2 (en) * 2013-01-26 2017-01-31 Sphaera Pharma Pvt. Ltd. Approach for synthesis of catechins
WO2020102325A1 (en) * 2018-11-13 2020-05-22 Yee Amy Compositions and methods of enhancing immunotherapies
CN113429371B (zh) * 2021-05-21 2022-06-21 浙江大学 一种原飞燕草素b9没食子酸酯的化学合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2745305A1 (de) 1977-10-07 1979-04-19 Bayer Ag Insektizide und akarizide mittel
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01
WO1999022728A1 (en) 1997-10-31 1999-05-14 Arch Development Corporation Methods and compositions for regulation of 5-alpha reductase activity
AU4043900A (en) 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
JP2001253879A (ja) 2000-03-09 2001-09-18 Shizuoka Prefecture カテキン類のアルキル誘導体
US6713506B2 (en) 2000-10-11 2004-03-30 University Of South Florida Tea polyphenol esters and analogs thereof for cancer prevention and treatment

Similar Documents

Publication Publication Date Title
JP2006510658A5 (enExample)
CN1091601C (zh) 用苯酚取代的二磷酸酯作抗肿瘤剂
CN1195514C (zh) 海鞘素 743的代谢物
SE0104334D0 (sv) Therapeutic agents
JP2009507909A5 (enExample)
WO2007139150A1 (ja) ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤
JP2009536191A5 (enExample)
US12466792B2 (en) Compounds for the treatment of SARS
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
CN115667209A (zh) 用于治疗sars的化合物
CA2302568A1 (en) Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
EP3134393B1 (en) Cyclohexenyl compounds, compositions comprising them and uses thereof
JP2005533760A5 (enExample)
JP2011508779A5 (enExample)
JP2005516898A5 (enExample)
CN1009826B (zh) 制备喹啉基化合物的方法
WO2018191642A1 (en) Novel amodiaquine analogs and methods of uses thereof
RU2008138749A (ru) Производные камптотецина и их применение
RU2007104176A (ru) Синтез и применение (-)-бета-элемена, (-)-бета-элеменала, (-)-бета-элеменола, фторида (-)-бета-элемена и их аналогов, а также промежуточных продуктов и композитов
CN111909204B (zh) 一种替诺福韦双苯丙酸酯基氨基磷酸酯化合物及其药物组合物和用途
US20070213378A1 (en) Compounds for modulating cell proliferation, compositions and methods related thereto
JP2005501121A5 (enExample)
JP2007525533A5 (enExample)
JP2003521457A5 (enExample)
JP2007507472A5 (enExample)